Barry Antonius Pepers

Title: Barry Antonius Pepers: Innovator in Antisense Oligonucleotide Technology

Introduction

Barry Antonius Pepers is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of molecular biology, particularly in the development of methods for modifying proteins through antisense oligonucleotides. With a total of 3 patents, his work has the potential to impact therapeutic approaches for various genetic conditions.

Latest Patents

Pepers' latest patents include innovative methods for the removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansions from proteins. One of his patents describes a method that involves providing a cell that expresses pre-mRNA encoding the protein with an antisense oligonucleotide. This oligonucleotide induces skipping of the exonic sequence that comprises the proteolytic cleavage site, HCHWA-D mutation, or trinucleotide repeat expansion. The method further includes allowing translation of the mRNA produced from the pre-mRNA. Another patent focuses specifically on the removal of proteolytic cleavage sites from proteins using a similar approach.

Career Highlights

Throughout his career, Barry Antonius Pepers has worked at prestigious institutions, including Academisch Ziekenhuis Leiden, also known as LUMC. His research has been pivotal in advancing the understanding of genetic modifications and their applications in medicine.

Collaborations

Pepers has collaborated with esteemed colleagues such as Wilhelmina M C Van Roon-Mom and Melvin Maurice Evers. These collaborations have contributed to the depth and breadth of his research endeavors.

Conclusion

Barry Antonius Pepers stands out as an influential inventor in the field of antisense oligonucleotide technology. His innovative patents and collaborative efforts continue to pave the way for advancements in genetic research and therapeutic applications.